DaltonTx

News

AI in drug discovery & development: News watch, October 2026

Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.

News

Meet Dalton, a new AI-powered drug discovery platform

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

MSD's $349m alliance with Variational, and other AI news

MSD signs $345m alliance with Variational AI, plus updates on AI in drug discovery projects from Bio Protocol, Dalton Tx, Virginia Tech, and Insilico.

AI in drug discovery & development: News watch, October 2026

Meet Dalton, a new AI-powered drug discovery platform

MSD's $349m alliance with Variational, and other AI news

Aspen, Bambusa close IPOs as Corxel takes SPAC route

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks